Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms

Free Radical Biology and Medicine

Volumn 105, Issue , 2017, Pages 3-15

  Wang, Xingmin ^a,b   Yang, Yonghong ^c,d   Huycke, Mark M ^b,e  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Oklahoma City Veterans Affair Medical Center   (United States)

^c Kangfu Hospital of Gansu Province   (China)

^d Lanzhou University Second Hospital   (Brazil)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer etiology; Cancer stem cell; Colon cancer; DNA damage; Microbiome; Mutagenesis

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; SULFATE; SUPEROXIDE;

AGING; APOPTOSIS; BACTEROIDES FRAGILIS; BYSTANDER EFFECT; CANCER GENETICS; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; COLON FLORA; COLORECTAL CANCER; DNA DAMAGE; ENTEROCOCCUS FAECALIS; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; ESCHERICHIA COLI; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INFLAMMATION; JC VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SENESCENCE; STREPTOCOCCUS GALLOLYTICUS; SULFATE REDUCING BACTERIUM; WART VIRUS; ANIMAL; CELL TRANSFORMATION; COLORECTAL TUMOR; ENTEROBACTERIACEAE; GENETICS; IMMUNOLOGY; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; COLORECTAL NEOPLASMS; DNA DAMAGE; ENTEROBACTERIACEAE; EPITHELIAL-MESENCHYMAL TRANSITION; GASTROINTESTINAL MICROBIOME; HUMANS; NEOPLASTIC STEM CELLS; RISK FACTORS;

EID: 85018493034     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.10.504     Document Type: Review

References (204)

1. [1] Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr., Kinzler, K.W., Cancer genome landscapes. Science 339 (2013), 1546–1558.
2. [2] Goel, A., Boland, C.R., Epigenetics of colorectal cancer. Gastroenterology 143 (2012), 1442–1460.
3. [3] Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15:3 (2014), 317–328.
4. [4] Schwabe, R.F., Jobin, C., The microbiome and cancer. Nat. Rev. Cancer 13:11 (2013), 800–812.
5. [5] Garrett, W.S., Cancer and the microbiota. Science 348:6230 (2015), 80–86.
6. [6] Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J. Clin. 64 (2014), 104–117.
7. [7] Shen, H., Yang, J., Huang, Q., Jiang, M.J., Tan, Y.N., Fu, J.F., Zhu, L.Z., Fang, X.F., Yuan, Y., Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J. Gastroenterol.(21), 2015, 6470–6478.
8. [8] Tamas, K., Walenkamp, A.M., de Vries, E.G., van Vugt, M.A., Beets-Tan, R.G., van Etten, B., de Groot, D.J., Hospers, G.A., Rectal and colon cancer: not just a different anatomic site. Cancer Treat. Rev. 41 (2015), 671–679.
9. [9] Carethers, J.M., Jung, B.H., Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149 (2015), 1177–1190 (e3).
10. [10] Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., Hemminki, K., Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343 (2000), 78–85.
11. [11] R.A. Weinberg, Multi-step Tumorigenesis, The Biology of Cancer, Garland Science, New York, NY, 2007, pp. 399-462.
12. [12] Martincorena, I., Campbell, P.J., Somatic mutation in cancer and normal cells. Science 349 (2015), 1483–1489.
13. [13] Shendure, J., Akey, J.M., The origins, determinants, and consequences of human mutations. Science 349 (2015), 1478–1483.
14. [14] Qubaiah, O., Devesa, S.S., Platz, C.E., Huycke, M.M., Dores, G.M., Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol. Biomark. Prev. 19 (2010), 1908–1918.
15. [15] Pellman, D., Cell biology: aneuploidy and cancer. Nature 446:7131 (2007), 38–39.
16. [16] Carethers, J.M., Koi, M., Tseng-Rogenski, S.S., EMAST is a form of microsatellite instability that is initiated by inflammation and modulates colorectal cancer progression. Genes 6 (2015), 185–205.
17. [17] Strum, W.B., Colorectal adenomas. N. Engl. J. Med. 374 (2016), 1065–1075.
18. [18] Hagland, H.R., Soreide, K., Cellular metabolism in colorectal carcinogenesis: influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett. 356 (2015), 273–280.
19. [19] Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon, France, 2012, pp. 1–538.
20. [20] Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic. Biol. Med. 49 (2010), 1603–1616.
21. [21] Franceschi, C., Campisi, J., Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med Sci. 69:Suppl 1 (2014), S4–S9.
22. [22] Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J. Clin. 64:2 (2014), 104–117.
23. [23] Burkitt, D.P., Epidemiology of cancer of the colon and rectum. Cancer 28 (1971), 3–13.
24. [24] Bardou, M., Barkun, A.N., Martel, M., Obesity and colorectal cancer. Gut 62 (2015), 933–947.
25. [25] Kushi, L.H., Doyle, C., McCullough, M., Rock, C.L., Demark-Wahnefried, W., Bandera, E.V., Gapstur, S., Patel, A.V., Andrews, K., Gansler, T., American cancer society guidelines on nutrition and physical activity for Cancer prevention: reducing the risk of Cancer with healthy food choices and physical activity. CA Cancer J. Clin. 62 (2012), 30–67.
26. [26] Birt, D.F., Phillips, G.J., Diet, genes, and microbes: complexities of colon cancer prevention. Toxicol. Pathol. 42 (2014), 182–188.
27. [27] Nehra, V., Allen, J.M., Mailing, L.J., Kashyap, P.C., Woods, J.A., Gut microbiota: modulation of host physiology in obesity. Physiology 31 (2016), 327–335.
28. [28] O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J.M., Kinross, J., Wahl, E., Ruder, E., Vipperla, K., Naidoo, V., Mtshali, L., Tims, S., Puylaert, P.G., DeLany, J., Krasinskas, A., Benefiel, A.C., Kaseb, H.O., Newton, K., Nicholson, J.K., de Vos, W.M., Gaskins, H.R., Zoetendal, E.G., Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun., 6, 2015, 6342.
29. [29] Chapple, K.S., Cartwright, E.J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A.C.J., Buillou, P.J., Markham, A.F., Coletta, P.L., Hull, M.A., Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol. 156 (2000), 545–553.
30. [30] Hardwick, J.C.H., van den Brink, G., Offerhaus, G.J., van Deventer, S.J.H., Peppelenbosch, M.P., NF-κB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 20 (2001), 819–827.
31. [31] Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R., Harris, C.C., Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58 (1998), 334–341.
32. [32] Speed, N., Blair, I.A., Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metast. Rev. 30 (2011), 437–447.
33. [33] Janakiram, N.B., Rao, C.V., The role of inflammation in colon cancer. Adv. Exp. Med. Biol. 816 (2014), 25–52.
34. [34] Wang, X., Yang, Y., Moore, D.R., Nimmo, S.L., Lightfoot, S.A., Huycke, M.M., 4-Hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142 (2012), 543–551.
35. [35] Wang, X., Allen, T.D., Yang, Y., Moore, D.R., Huycke, M.M., Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages. Cancer Prev. Res. 6:3 (2013), 206–216.
36. [36] Fischer, S.M., Hawk, E.T., Lubet, R.A., Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev. Res. 4 (2011), 1728–1735.
37. [37] Thun, M.J., Jacobs, E.J., Patrono, C., The role of aspirin in cancer prevention. Nat. Rev. Clin. Oncol. 9 (2012), 259–267.
38. [38] Edwards, B.K., Ward, E., Kohler, B.A., Eheman, C., Zauber, A.G., Anderson, R.N., Jemal, A., Schymura, M.J., Lansdorp-Vogelaar, I., Seeff, L.C., van Ballegooijen, M., Goede, S.L., Ries, L.A., Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
39. [39] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
40. [40] Zoetendal, E.G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A.D., de Vos, W.M., Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68 (2002), 3401–3407.
41. [41] Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkila, J., Monti, D., Satokari, R., Franceschi, C., Brigidi, P., Vos, W. De, Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5, 2010, e10667.
42. [42] Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J.R., Falush, D., Dinan, T., Fitzgerald, G., Stanton, C., van Sinderen, D., O'Connor, M., Harnedy, N., O'Connor, K., Henry, C., O'Mahony, D., Fitzgerald, A.P., Shanahan, F., Twomey, C., Hill, C., Ross, R.P., O'Toole, P.W., Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2010), S4586–S4591.
43. [43] Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J.J., Hayes, R.B., Yang, L., Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 105 (2013), 1907–1911.
44. [44] Tjalsma, H., Boleij, A., Marchesi, J.R., Dutilh, B.E., A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10 (2012), 575–582.
45. [45] Bäckhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
46. [46] Goodrich, J.K., Davenport, E.R., Beaumont, M., Jackson, M.A., Knight, R., Ober, C., Spector, T.D., Bell, J.T., Clark, A.G., Ley, R.E., Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19 (2016), 731–743.
47. [47] Dickinson, R.E., Dallol, A., Bieche, I., Krex, D., Morton, D., Maher, E.R., Latif, F., Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br. J. Cancer 91 (2004), 2071–2078.
48. [48] Dejea, C.M., Wick, E.C., Hechenbleikner, E.M., White, J.R., Mark Welch, J.L., Rossetti, B.J., Peterson, S.N., Snesrud, E.C., Borisy, G.G., Lazarev, M., Stein, E., Vadivelu, J., Roslani, A.C., Malik, A.A., Wanyiri, J.W., Goh, K.L., Thevambiga, I., Fu, K., Wan, F., Llosa, N., Housseau, F., Romans, K., Wu, X., McAllister, F.M., Wu, S., Vogelstein, B., Kinzler, K.W., Pardoll, D.M., Sears, C.L., Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. USA 111 (2014), 18321–18326.
49. [49] Johnson, C.H., Dejea, C.M., Edler, D., Hoang, L.T., Santidrian, A.F., Felding, B.H., Ivanisevic, J., Cho, K., Wick, E.C., Hechenbleikner, E.M., Uritboonthai, W., Goetz, L., Casero, R.A. Jr., Pardoll, D.M., White, J.R., Patti, G.J., Sears, C.L., Siuzdak, G., Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21 (2015), 891–897.
50. [50] Wilson, K.T., Polyamine- and NADPH-dependent generation of reactive oxygen species during Helicobacer pylori infection: the double-edged sword of innate immunity. Free Radic. Biol. Med. Suppl., 2017 in press.
51. [51] Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., Ojesina, A.I., Jung, J., Bass, A.J., Tabernero, J., Baselga, J., Liu, C., Shivdasani, R.A., Ogino, S., Birren, B.W., Huttenhower, C., Garrett, W.S., Meyerson, M., Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22:2 (2012), 292–298.
52. [52] Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206.
53. [53] Ridlon, J.M., Wolf, P.G., Gaskins, H.R., Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 7 (2016), 201–215.
54. [54] Toprak, N.U., Yagci, A., Gulluoglu, B.M., Akin, M.L., Demirkalem, P., Celenk, T., Soyletir, G., A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12 (2006), 782–786.
55. [55] Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., Rhodes, J.M., Stintzi, A., Simpson, K.W., Hansen, J.J., Keku, T.O., Fodor, A.A., Jobin, C., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
56. [56] Balamurugan, R., Rajendiran, E., George, S., Samuel, G.V., Ramakrishna, B.S., Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J. Gastroenterol. Hepatol. 23 (2008), 1298–1303.
57. [57] Fu, J., Wei, B., Wen, T., Johansson, M.E., Liu, X., Bradford, E., Thomsson, K.A., McGee, S., Mansour, L., Tong, M., McDaniel, J.M., Sferra, T.J., Turner, J.R., Chen, H., Hansson, G.C., Braun, J., Xia, L., Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Investig. 121 (2012), 1657–1666.
58. [58] Kim, S.C., Tonkonogy, S.L., Albright, C.A., Tsang, J., Balish, E.J., Braun, J., Huycke, M.M., Sartor, R.B., Variable phenotypes of enterocolitis in IL-10 deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 (2005), 891–906.
59. [59] Maggio-Price, L., Treuting, P., Zeng, W., Tsang, M., Bielefeldt-Ohmann, H., Iritani, B.M., Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res. 66 (2006), 828–838.
60. [60] Chu, F.F., Esworthy, R.S., Chu, P.G., Longmate, J.A., Huycke, M.M., Wilczynski, S., Doroshow, J.H., Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res. 64 (2004), 962–968.
61. [61] Engle, S.J., Ormsby, I., Pawlowski, S., Boivin, G.P., Croft, J., Balish, E., Doetschman, T., Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res. 62 (2002), 6362–6366.
62. [62] Kado, S., Uchida, K., Funabashi, H., Iwata, S., Nagata, Y., Ando, M., Onoue, M., Matsuoka, Y., Ohwaki, M., Morotomi, M., Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 61 (2001), 2395–2398.
63. Min mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57 (1997), 812–814.
64. [64] Bergstron, K., Liu, X., Gao, N., Song, K., Cui, Y., Li, Y., McDaniel, M., McGee, S., Chen, W., Huycke, M.M., Houchen, C.W., Zenewica, L.A., West, C.M., Chen, H., Braun, J., Fu, J., Xia, L., Defective intestinal mucin-type O-glycosylation causes spontaneous colitis-associated cancer in mice. Gastroenterology 151 (2016), 152–164.
65. [65] Man, S.M., Zhu, Q., Zhu, L., Liu, Z., Karki, R., Malik, A., Sharma, D., Li, L., Malireddi, R.K., Gurung, P., Neale, G., Olsen, S.R., Carter, R.A., McGoldrick, D.J., Wu, G., Finkelstein, D., Vogel, P., Gilbertson, R.J., Kanneganti, T.D., Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell 162 (2015), 45–58.
66. [66] Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye-Crespin, A., Gaillot, O., Schreiber, S., Lemoine, Y., Ryffel, B., Hot, D., Nunez, G., Chen, G., Rosenstiel, P., Chamaillard, M., NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Investig. 123 (2013), 700–711.
67. [67] Thaiss, C.A., Zmora, N., Levy, M., Elinav, E., The microbiome and innate immunity. Nature 535 (2016), 65–74.
68. [68] Picard, C., Fioramonti, J., Francois, A., Robinson, T., Neant, F., Matuchansky, C., Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22 (2005), 495–512.
69. [69] Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., Chang, E.B., Gajewski, T.F., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 6264 (2015), 1084–1089.
70. [70] Geier, M.S., Butler, R.N., Howarth, G.S., Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. Cancer Biol. Ther. 5 (2006), 1265–1269.
71. [71] Zhan, Y., Chen, P.J., Sadler, W.D., Wang, F., Poe, S., Nunez, G., Eaton, K.A., Chen, G.Y., Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res. 73 (2013), 7199–7210.
72. [72] Ambalam, P., Raman, M., Purama, R.K., Doble, M., Probiotics, prebiotics and colorectal cancer prevention. Best Pract. Res. Clin. Gastroenterol. 30 (2016), 119–131.
73. [73] Negroni, A., Cucchiara, S., Stronati, L., Apoptosis, necrosis, and necroptosis in the gut and Iintestinal homeostasis. Mediat. Inflamm., 2015, 2015, 250762.
74. [74] Loktionov, A., Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int. J. Cancer 120 (2007), 2281–2289.
75. [75] Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., Augenlicht, L., Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295 (2002), 1726–1729.
76. [76] Larsson, J.M., Karlsson, H., Crespo, J.G., Johansson, M.E., Eklund, L., Sjovall, H., Hansson, G.C., Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm. Bowel Dis. 17 (2011), 2299–2307.
77. [77] Itzkowitz, S.H., Young, E., Dubois, D., Harpaz, N., Bodian, C., Chen, A., Sachar, D.B., Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology 110 (1996), 694–704.
78. [78] Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evolut. Microbiol. 54 (2004), 1469–1476.
79. [79] Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., de Vos, W.M., Cani, P.D., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
80. [80] Thiele Orberg, E., Fan, H., Tam, A.J., Dejea, C.M., Destefano Shields, C.E., Wu, S., Chung, L., Finard, B.B., Wu, X., Fathi, P., Ganguly, S., Fu, J., Pardoll, D.M., Sears, C.L., Housseau, F., The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol., 2016, 10.1038/mi.2016.53.
81. [81] Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., Housseau, F., Pardoll, D.M., Sears, C.L., A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15 (2009), 1016–1022.
82. [82] M. Prorok-Hamon, M.K. Friswell, A. Alswied, C.L. Roberts, F. Song, P.K. Flanagan, P. Knight, C. Codling, J.R. Marchesi, C. Winstanley, N. Hall, J.M. Rhodes, B.J. Campbell, Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer, Gut, vol. 63 pp. 761–770.
83. [83] Kraehenbuhl, J.P., Neutra, M.R., Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16 (2000), 301–332.
84. [84] Wells, C.L., Jechorek, R.P., Erlandsen, S.L., Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract. J. Infect. Dis. 162 (1990), 82–90.
85. [85] Hollowell, J.G. Jr., Littlefield, L.G., Chromosome damage induced by plasma of x-rayed patients: an indirect effect of x-ray. Proc. Soc. Exp. Biol. Med. 129 (1968), 240–244.
86. [86] Goh, K., Sumner, H., Breaks in normal human chromosomes: are they induced by a transferable substance in the plasma of persons exposed to total-body irradiation?. Radiat. Res. 35 (1968), 171–181.
87. [87] Lorimore, S.A., Wright, E.G., Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to Radiation-induced stress and injury?. Rev. Int. J. Radiat. Biol. 79 (2003), 15–25.
88. [88] Pant, G.S., Kamada, N., Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals. Hiroshima J. Med. 26 (1977), 149–154.
89. [89] Marozik, P., Mothersill, C., Seymour, C.B., Mosse, I., Melnov, S., Bystander effects induced by serum from survivors of the Chernobyl accident. Exp. Hematol. 35 (2007), 55–63.
90. [90] Watson, G.E., Lorimore, S.A., Macdonald, D.A., Wright, E.G., Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res. 60 (2000), 5608–5611.
91. [91] Wang, X., Huycke, M.M., Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132 (2007), 551–561.
92. [92] Wang, X., Yang, Y., Huycke, M.M., Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut 64 (2015), 459–468.
93. [93] Wang, X., Huycke, M.M., Colorectal cancer: role of commensal bacteria and bystander effects. Gut Microbes 6:6 (2015), 370–376.
94. [94] Emerit, I., Clastogenic factors as potential biomarkers of increased superoxide production. Biomark. Insights 2 (2007), 429–438.
95. [95] Yang, Y., Wang, X., Moore, D.R., Lightfoot, S.A., Huycke, M.M., TNF-α mediates macrophage-induced bystander effects through netrin-1. Cancer Res. 72 (2012), 5219–5229.
96. [96] Yang, Y., Huycke, M.M., Herman, T.S., Wang, X., Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer. Oncogene, 11, 2016, 2016, 10.1038/onc.2016.113.
97. [97] Zeuner, A., Todaro, M., Stassi, G., Maria, R. De, Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell 15:6 (2014), 692–705.
98. [98] Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009), 608–611.
99. [99] Friedmann-Morvinski, D., Verma, I.M., Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 15:3 (2014), 244–253.
100. [100] Chaffer, C.L., Brueckmann, I., Scheel, C., Kaestli, A.J., Wiggins, P.A., Rodrigues, L.O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., Arendt, L.M., Kuperwasser, C., Bierie, B., Weinberg, R.A., Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. USA 108:19 (2011), 7950–7955.
101. [101] Gerbe, F., van Es, J.H., Makrini, L., Brulin, B., Mellitzer, G., Robine, S., Romagnolo, B., Shroyer, N.F., Bourgaux, J.F., Pignodel, C., Clevers, H., Jay, P., Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J. Cell Biol. 192 (2011), 767–780.
102. [102] von Moltke, J., Ji, M., Liang, H.E., Locksley, R.M., Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529 (2016), 221–225.
103. [103] May, R., Qu, D., Weygant, N., Chandrakesan, P., Ali, N., Lightfoot, S.A., Li, L., Sureban, S.M., Houchen, C.W., Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury. Stem Cells 32 (2014), 822–827.
104. [104] Chandrakesan, P., Weygant, N., May, R., Qu, D., Chinthalapally, H.R., Sureban, S.M., Ali, N., Lightfoot, S.A., Umar, S., Houchen, C.W., DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition. Oncotarget 5 (2014), 9269–9280.
105. [105] Nakanishi, Y., Seno, H., Fukuoka, A., Ueo, T., Yamaga, Y., Maruno, T., Nakanishi, N., Kanda, K., Komekado, H., Kawada, M., Isomura, A., Kawada, K., Sakai, Y., Yanagita, M., Kageyama, R., Kawaguchi, Y., Taketo, M.M., Yonehara, S., Chiba, T., Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat. Genet 45 (2012), 98–103.
106. [106] Westphalen, C.B., Asfaha, S., Hayakawa, Y., Takemoto, Y., Lukin, D.J., Nuber, A.H., Brandtner, A., Setlik, W., Remotti, H., Muley, A., Chen, X., May, R., Houchen, C.W., Fox, J.G., Gershon, M.D., Quante, M., Wang, T.C., Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J. Clin. Investig. 124 (2014), 1283–1295.
107. [107] Sureban, S.M., May, R., Mondalek, F.G., Qu, D., Ponnurangam, S., Pantazis, P., Anant, S., Ramanujam, R.P., Houchen, C.W., Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J. Nanobiotechnol., 9, 2011, 40.
108. [108] MacDonald, B.T., Tamai, K., He, X., Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17:1 (2009), 9–26.
109. [109] Clevers, H., Loh, K.M., Nusse, R., Stem cell signaling. An integral program for tissue renewal and regeneration: wnt signaling and Stem cell control. Science, 346, 2014, 10.1126/science.1248012.
110. [110] Schwitalla, S., Fingerle, A.A., Cammareri, P., Nebelsiek, T., Goktuna, S.I., Ziegler, P.K., Canli, O., Heijmans, J., Huels, D.J., Moreaux, G., Rupec, R.A., Gerhard, M., Schmid, R., Barker, N., Clevers, H., Lang, R., Neumann, J., Kirchner, T., Taketo, M.M., van den Brink, G.R., Sansom, O.J., Arkan, M.C., Greten, F.R., Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152:1–2 (2013), 25–38.
111. [111] Wu, S., Lim, K.C., Huang, J., Saidi, R.F., Sears, C.L., Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95:25 (1998), 14979–14984.
112. [112] Wu, S., Morin, P.J., Maouyo, D., Sears, C.L., Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124 (2003), 392–400.
113. [113] Yang, Y., Wang, X., Huycke, T., Moore, D.R., Lightfoot, S.A., Huycke, M.M., Colon macrophages polarized by commensal bacteria cause colitis and cancer through the bystander effect. Transl. Oncol. 6 (2013), 596–606.
114. [114] Majumder, M., Xin, X., Liu, L., Tutunea-Fatan, E., Rodriguez-Torres, M., Vincent, K., Postovit, L.M., Hess, D., Lala, P.K., COX-2 induces breast cancer stem cells via EP4/PI3K/AKT/NOTCH/WNT axis. Stem Cells, 2016, 10.1002/stem.2426.
115. 2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology 149 (2015), 1884–1895.
116. [116] Kim, J.M., Lee, J.Y., Yoon, Y.M., Oh, Y.K., Kang, J.S., Kim, Y.J., Kim, K.H., Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation. Eur. J. Immunol. 36 (2006), 2446–2456.
117. [117] Jones, R.M., Luo, L., Ardita, C.S., Richardson, A.N., Kwon, Y.M., Mercante, J.W., Alam, A., Gates, C.L., Wu, H., Swanson, P.A., Lambeth, J.D., Denning, P.W., Neish, A.S., Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 32 (2013), 3017–3028.
118. [118] Neish, A.S., Redox regulation of the epithelial-microbiota interface. Free Radic. Biol. Med. Suppl., 2017 in press.
119. [119] Singh, A., Settleman, J., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:34 (2010), 4741–4751.
120. [120] Hwang, W.L., Yang, M.H., Tsai, M.L., Lan, H.Y., Su, S.H., Chang, S.C., Teng, H.W., Yang, S.H., Lan, Y.T., Chiou, S.H., Wang, H.W., SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141 (2011), 279–291.
121. [121] Hofman, P., Vouret-Craviari, V., Microbes-induced EMT at the crossroad of inflammation and cancer. Gut Microbes 3:3 (2012), 176–185.
122. [122] Tahoun, A., Mahajan, S., Paxton, E., Malterer, G., Donaldson, D.S., Wang, D., Tan, A., Gillespie, T.L., O'Shea, M., Roe, A.J., Shaw, D.J., Gally, D.L., Lengeling, A., Mabbott, N.A., Haas, J., Mahajan, A., Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host Microbe 12:5 (2012), 645–656.
123. [123] Chandrakesan, P., Roy, B., Jakkula, L.U., Ahmed, I., Ramamoorthy, P., Tawfik, O., Papineni, R., Houchen, C., Anant, S., Umar, S., Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene 33:20 (2014), 2639–2654.
124. [124] Nougayrede, J.P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., Oswald, E., Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313 (2006), 848–851.
125. [125] Homburg, S., Oswald, E., Hacker, J., Dobrindt, U., Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol. Lett. 275:2 (2007), 255–262.
126. [126] Cuevas-Ramos, G., Petit, C.R., Marcq, I., Boury, M., Oswald, E., Nougayrède, J.P., Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 107 (2010), 11537–11542.
127. [127] Vizcaino, M.I., Crawford, J.M., The colibactin warhead crosslinks DNA. Nat. Chem. 7:5 (2015), 411–417.
128. [128] Guidi, R., Guerra, L., Levi, L., Stenerlow, B., Fox, J.G., Josenhans, C., Masucci, M.G., Frisan, T., Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell Microbiol. 15:1 (2013), 98–113.
129. [129] Lara-Tejero, M., Galan, J.E., A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:5490 (2000), 354–357.
130. [130] Mangerich, A., Knutson, C.G., Parry, N.M., Muthupalani, S., Ye, W., Prestwich, E., Cui, L., McFaline, J.L., Mobley, M., Ge, Z., Taghizadeh, K., Wishnok, J.S., Wogan, G.N., Fox, J.G., Tannenbaum, S.R., Dedon, P.C., Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc. Natl. Acad. Sci. USA 109:27 (2012), E1820–E1829.
131. [131] Rey, F.E., Gonzalez, M.D., Cheng, J., Wu, M., Ahern, P.P., Gordon, J.I., Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc. Natl. Acad. Sci. USA 110:33 (2013), 13582–13587.
132. [132] Loubinoux, J., Bronowicki, J.P., Pereira, I.A., Mougenel, J.L., Faou, A.E., Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol. Ecol. 40:2 (2002), 107–112.
133. [133] Attene-Ramos, M.S., Nava, G.M., Muellner, M.G., Wagner, E.D., Plewa, M.J., Gaskins, H.R., DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ. Mol. Mutagen. 51 (2010), 304–314.
134. [134] Attene-Ramos, M.S., Wagner, E.D., Gaskins, H.R., Plewa, M.J., Hydrogen sulfide induces direct radical-associated DNA damage. Mol. Cancer Res. 5:5 (2007), 455–459.
135. -/- mice. Nature 487:7405 (2012), 104–108.
136. [136] Sears, C.L., Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22 (2009), 349–369.
137. [137] Goodwin, A.C., Destefano Shields, C.E., Wu, S., Huso, D.L., Wu, X., Murray-Stewart, T.R., Hacker-Prietz, A., Rabizadeh, S., Woster, P.M., Sears, C.L., Casero, R.A. Jr., Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. USA 108:37 (2011), 15354–15359.
138. [138] Huycke, M.M., Moore, D., Joyce, W., Wise, P., Shepard, L., Kotake, Y., Gilmore, M.S., Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol. Microbiol. 42 (2001), 729–740.
139. [139] Huycke, M.M., Joyce, W., Wack, M.F., Augmented production of extracellular superoxide production by blood isolates of Enterococcus faecalis. J. Infect. Dis. 173 (1996), 743–746.
140. [140] Huycke, M.M., Moore, D.R., In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic. Biol. Med. 33 (2002), 818–826.
141. [141] M. Ramsey, A. Hartke, M. Huycke, The Physiology and metabolism of Enterococci, in: M.S. Gilmore, D.B. Clewell, Y. Ike, N. Shankar (Eds.), Enterococci: From Commensals to Leading Causes of Drug Resistant Infection (Internet), 2014.
142. [142] Huycke, M.M., Abrams, V., Moore, D.R., Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23 (2002), 529–536.
143. [143] Wang, X., Allen, T.D., May, R.J., Lightfoot, S., Houchen, C.W., Huycke, M.M., Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 68 (2008), 9909–9917.
144. [144] Allen, T.D., Moore, D.R., Wang, X., Casu, V., May, R., Lerner, M.R., Houchen, C., Brackett, D.J., Huycke, M.M., Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression. J. Med. Microbiol. 57 (2008), 1193–1204.
145. [145] Zhou, H., Ivanov, V.N., Gillespie, J., Geard, C.R., Amundson, S.A., Brenner, D.J., Yu, Z., Lieberman, H.B., Hei, T.K., Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathway. Proc. Natl. Acad. Sci. USA 102 (2005), 14641–14646.
146. [146] Lu, R., Wu, S., Zhang, Y.G., Xia, Y., Liu, X., Zheng, Y., Chen, H., Schaefer, K.L., Zhou, Z., Bissonnette, M., Li, L., Sun, J., Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis, 3, 2014, e105.
147. [147] Lu, R., Wu, S., Zhang, Y.G., Xia, Y., Zhou, Z., Kato, I., Dong, H., Bissonnette, M., Sun, J., Salmonella protein AvrA activates the STAT3 signaling pathway in colon cancer. Neoplasia 18:5 (2016), 307–316.
148. [148] Wu, H., Jones, R.M., Neish, A.S., The Salmonella effector AvrA mediates bacterial intracellular survival during infection in vivo. Cell Microbiol. 14:1 (2012), 28–39.
149. [149] Jones, R.M., Wu, H., Wentworth, C., Luo, L., Collier-Hyams, L., Neish, A.S., Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3:4 (2008), 233–244.
150. [150] Ashman, L.K., Cook, M.G., Kotlarski, I., Protective effect of oral Salmonella enteritidis 11RX infection against colon tumor induction by 1,2-dimethylhydrazine in mice. Cancer Res. 39:7 Pt 1 (1979), 2768–2771.
151. [151] Klein, R.S., Recco, R.A., Catalano, M.T., Edberg, S.C., Casey, J.I., Steigbigel, N.H., Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med. 297:15 (1977), 800–802.
152. [152] Boleij, A., Tjalsma, H., The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect. Dis. 13:8 (2013), 719–724.
153. [153] Ellmerich, S., Scholler, M., Duranton, B., Gosse, F., Galluser, M., Klein, J.P., Raul, F., Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21:4 (2000), 753–756.
154. [154] Biarc, J., Nguyen, I.S., Pini, A., Gosse, F., Richert, S., Thierse, D., Van Dorsselaer, A., Leize-Wagner, E., Raul, F., Klein, J.P., Scholler-Guinard, M., Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 25:8 (2004), 1477–1484.
155. [155] Shen, X.J., Rawls, J.F., Randall, T., Burcal, L., Mpande, C.N., Jenkins, N., Jovov, B., Abdo, Z., Sandler, R.S., Keku, T.O., Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1:3 (2010), 138–147.
156. [156] Abdulamir, A.S., Hafidh, R.R., Bakar, F.A., Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol. Cancer, 9, 2010, 249.
157. [157] Sillanpaa, J., Nallapareddy, S.R., Qin, X., Singh, K.V., Muzny, D.M., Kovar, C.L., Nazareth, L.V., Gibbs, R.A., Ferraro, M.J., Steckelberg, J.M., Weinstock, G.M., Murray, B.E., A collagen-binding adhesin, Acb, and ten other putative MSCRAMM and pilus family proteins of Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis Group, biotype I). J. Bacteriol. 191:21 (2009), 6643–6653.
158. [158] Skovbjerg, H., Anthonsen, D., Lothe, I.M., Tveit, K.M., Kure, E.H., Vogel, L.K., Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer, 9, 2009, 136.
159. [159] Galbavy, S., Lukac, L., Porubsky, J., Cerna, M., Labuda, M., Kmet'ova, J., Papincak, J., Durdik, S., Jakubovsky, J., Collagen type IV in epithelial tumours of colon. Acta Histochem. 104:4 (2002), 331–334.
160. [160] Biological agents. Volume 100 B. A review of human carcinogens, in: W.H. Organization (Ed.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon, France, 2012, pp. 1–441.
161. [161] Bodaghi, S., Yamanegi, K., Xiao, S.Y., Da Costa, M., Palefsky, J.M., Zheng, Z.M., Colorectal papillomavirus infection in patients with colorectal cancer. Clin. Cancer Res. 11 (2005), 2862–2867.
162. [162] Damin, D.C., Caetano, M.B., Rosito, M.A., Schwartsmann, G., Damin, A.S., Frazzon, A.P., Ruppenthal, R.D., Alexandre, C.O., Evidence for an association of human papillomavirus infection and colorectal cancer. Eur. J. Surg. Oncol. 33 (2007), 569–574.
163. [163] Angioli, R., Lopez, S., Aloisi, A., Terranova, C., De Cicco, C., Scaletta, G., Capriglione, S., Miranda, A., Luvero, D., Ricciardi, R., Montera, R., Plotti, F., Ten years of HPV vaccines: state of art and controversies. Crit. Rev. Oncol. Hematol. 102 (2016), 65–72.
164. [164] Goel, A., Li, M.S., Nagasaka, T., Shin, S.K., Fuerst, F., Ricciardiello, L., Wasserman, L., Boland, C.R., Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology 130 (2006), 1950–1961.
165. [165] Link, A., Shin, S.K., Nagasaka, T., Balaguer, F., Koi, M., Jung, B., Boland, C.R., Goel, A., JC virus mediates invasion and migration in colorectal metastasis. PLoS One(12), 2009, e8146.
166. [166] Ricciardiello, L., Baglioni, M., Giovannini, C., Pariali, M., Cenacchi, G., Ripalti, A., Landini, M.P., Sawa, H., Nagashima, K., Frisque, R.J., Goel, A., Boland, C.R., Tognon, M., Roda, E., Bazzoli, F., Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res. 63 (2003), 7256–7262.
167. [167] Kim, J.M., Lee, J.Y., Yoon, Y.M., Oh, Y.K., Kang, J.S., Kim, Y.J., Kim, K.H., Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation. Eur. J. Immunol. 36:9 (2006), 2446–2456.
168. [168] Fukata, M., Abreu, M.T., Role of toll-like receptors in gastrointestinal malignancies. Oncogene 27:2 (2008), 234–243.
169. [169] Fukata, M., Chen, A., Klepper, A., Krishnareddy, S., Vamadevan, A.S., Thomas, L.S., Xu, R., Inoue, H., Arditi, M., Dannenberg, A.J., Abreu, M.T., Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131:3 (2006), 862–877.
170. [170] Schirbel, A., Kessler, S., Rieder, F., West, G., Rebert, N., Asosingh, K., McDonald, C., Fiocchi, C., Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis. Gastroenterology 144:3 (2013), 613–623 (e9).
171. [171] Moroni, M., Veronese, S., Benvenuti, S., Marrapese, G., Sartore-Bianchi, A., Di Nicolantonio, F., Gambacorta, M., Siena, S., Bardelli, A., Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol. 6 (2005), 279–286.
172. [172] Boonanantanasarn, K., Gill, A.L., Yap, Y., Jayaprakash, V., Sullivan, M.A., Gill, S.R., Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation. Infect. Immun. 80:10 (2012), 3545–3558.
173. [173] Kim, J.M., Lee, J.Y., Kim, Y.J., Inhibition of apoptosis in Bacteroides fragilis enterotoxin-stimulated intestinal epithelial cells through the induction of c-IAP-2. Eur. J. Immunol. 38:8 (2008), 2190–2199.
174. [174] Mehlen, P., Delloye-Bourgeois, C., Chédotal, A., Novel roles for Slits and netrins: axon guidance cues as anticancer targets?. Nat. Rev. Cancer 11 (2011), 188–197.
175. [175] Cerbone, A., Toaldo, C., Laurora, S., Briatore, F., Pizzimenti, S., Dianzani, M.U., Ferretti, C., Barrera, G., 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. Free Radic. Biol. Med. 42:11 (2007), 1661–1670.
176. [176] Kumagai, T., Nakamura, Y., Osawa, T., Uchida, K., Role of p38 mitogen-activated protein kinase in the 4-hydroxy-2-nonenal-induced cyclooxygenase-2 expression. Arch. Biochem. Biophys. 397:2 (2002), 240–245.
177. [177] Tammali, R., Ramana, K.V., Singhal, S.S., Awasthi, S., Srivastava, S.K., Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res. 66:19 (2006), 9705–9713.
178. [178] Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A., Bringer, M.A., Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab Investig. 95:3 (2015), 296–307.
179. [179] Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Dechelotte, P., Bonnet, M., Pezet, D., Wodrich, H., Darfeuille-Michaud, A., Bonnet, R., Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63:12 (2014), 1932–1942.
180. [180] Secher, T., Samba-Louaka, A., Oswald, E., Nougayrede, J.P., Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One, 8(10), 2013, e77157.
181. [181] Mima, K., Nishihara, R., Qian, Z.R., Cao, Y., Sukawa, Y., Nowak, J.A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A.D., Giannakis, M., Bullman, S., Milner, D.A., Baba, H., Giovannucci, E.L., Garraway, L.A., Freeman, G.J., Dranoff, G., Garrett, W.S., Huttenhower, C., Meyerson, M., Meyerhardt, J.A., Chan, A.T., Fuchs, C.S., Ogino, S., Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut, 2015, 10.1136/gutjnl-2015-310101.
182. [182] Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.O., Sugai, T., An, B., Shureiqi, I., Toyota, M., Kondo, Y., Estecio, M.R., Issa, J.P., Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74 (2014), 1311–1318.
183. [183] Davie, J.R., Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003), 2485S–2493S.
184. [184] Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., Bultman, S.J., The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48 (2012), 612–626.
185. [185] Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E.H., Copeland, J.K., Kumar, S., Green, B., Geddes, K., Pezo, R.C., Navarre, W.W., Milosevic, M., Wilson, B.C., Girardin, S.E., Wolever, T.M., Edelmann, W., Guttman, D.S., Philpott, D.J., Martin, A., Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158 (2014), 288–299.
186. [186] Kellermayer, R., Dowd, S.E., Harris, R.A., Balasa, A., Schaible, T.D., Wolcott, R.D., Tatevian, N., Szigeti, R., Li, Z., Versalovic, J., Smith, C.W., Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 25:5 (2011), 1449–1460.
187. [187] Yin, L., Chung, W.O., Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol. 4:4 (2011), 409–419.
188. [188] Cortese, R., Lu, L., Yu, Y., Ruden, D., Claud, E.C., Epigenome-Microbiome crosstalk: a potential new paradigm influencing neonatal susceptibility to disease. Epigenetics 11:3 (2016), 205–215.
189. [189] Lightfoot, Y.L., Yang, T., Sahay, B., Mohamadzadeh, M., Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus. Gut Microbes 4 (2013), 84–88.
190. [190] Verma, S., Mohapatra, G., Ahmad, S.M., Rana, S., Jain, S., Khalsa, J.K., Srikanth, C.V., Salmonella engages host microRNAs to modulate SUMOylation: a new arsenal for intracellular survival. Mol. Cell Biol. 35 (2015), 2932–2946.
191. [191] Strickertsson, J.A., Rasmussen, L.J., Friis-Hansen, L., Enterococcus faecalis infection and reactive oxygen species down-regulates the miR-17-92 cluster in gastric adenocarcinoma cell culture. Genes, 5, 2014, 726–738.
192. [192] Erdman, S.E., Gut microbiota modulate host immune cells in cancer development and growth. Free Radic. Biol. Med. Suppl., 2017 in press.
193. [193] Gentry-Weeks, C.R., Karkhoff-Schweizer, R., Pikis, A., Estay, M., Keith, J.M., Survival of Enterococcus faecalis in mouse peritoneal macrophages. Infect. Immun. 67 (1999), 2160–2165.
194. [194] Zou, J., Shankar, N., The opportunistic pathogen Enterococcus faecalis resists phagosome acidification and autophagy to promote intracellular survival in macrophages. Cell Microbiol. 18 (2016), 831–843.
195. [195] Kullberg, M.C., Jankovic, D., Feng, C.G., Hue, S., Gorelick, P.L., McKenzie, B.S., Cua, D.J., Powrie, F., Cheever, A.W., Maloy, K.J., Sher, A., IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:11 (2006), 2485–2494.
196. [196] Thiele Orberg, E., Fan, H., Tam, A.J., Dejea, C.M., Destefano Shields, C.E., Wu, S., Chung, L., Finard, B.B., Wu, X., Fathi, P., Ganguly, S., Fu, J., Pardoll, D.M., Sears, C.L., Housseau, F., The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol., 2016.
197. [197] Geis, A.L., Fan, H., Wu, X., Wu, S., Huso, D.L., Wolfe, J.L., Sears, C.L., Pardoll, D.M., Housseau, F., Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discov. 5:10 (2015), 1098–1109.
198. [198] Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E.M., O'Shea J, J., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:3 (2007), 371–381.
199. [199] Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., El-Omar, E.M., Brenner, D., Fuchs, C.S., Meyerson, M., Garrett, W.S., Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14:2 (2013), 207–215.
200. [200] Yu, J., Feng, Q., Wong, S.H., Zhang, D., Liang, Q.Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., Wang, X., Xu, X., Chen, N., Wu, W.K., Al-Aama, J., Nielsen, H.J., Kiilerich, P., Jensen, B.A., Yau, T.O., Lan, Z., Jia, H., Li, J., Xiao, L., Lam, T.Y., Ng, S.C., Cheng, A.S., Wong, V.W., Chan, F.K., Xu, X., Yang, H., Madsen, L., Datz, C., Tilg, H., Wang, J., Brunner, N., Kristiansen, K., Arumugam, M., Sung, J.J., Wang, J., Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut, 2015, 10.1136/gutjnl-2015-309800.
201. [201] Yoshida, Y., Ito, S., Kamo, M., Kezuka, Y., Tamura, H., Kunimatsu, K., Kato, H., Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586. Microbiology 156:Pt 7 (2010), 2260–2269.
202. [202] Attene-Ramos, M.S., Wagner, E.D., Plewa, M.J., Gaskins, H.R., Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 4 (2006), 9–14.
203. [203] Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., Shussman, N., Almogy, G., Cuapio, A., Hofer, E., Mevorach, D., Tabib, A., Ortenberg, R., Markel, G., Miklic, K., Jonjic, S., Brennan, C.A., Garrett, W.S., Bachrach, G., Mandelboim, O., Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42:2 (2015), 344–355.
204. [204] Abed, J., Emgard, J.E., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K.A., Mellul, A., Chaushu, S., Manson, A.L., Earl, A.M., Ou, N., Brennan, C.A., Garrett, W.S., Bachrach, G., Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20:2 (2016), 215–225.